Journal of Kerman University of Medical Sciences

New-Onset Psychosis Associated with COVID-19: A Case Report

Document Type : Case Report

Authors

I Ketut Arya Santosa 1
Wati Evilia 2
I Wayan Yuna Ariawan 3
I Komang Ana Mahardika 1
Marianto Marianto 1

1 Department of Psychiatry, Bali Provincial Mental Hospital, Bali, Indonesia

2 Department of Psychiatry, Udayana University/Sanglah General Hospital, Bali, Indonesia

3 Department of Internal Medicine, Bali Provincial Mental Hospital, Bali, Indonesia

https://doi.org/10.22062/jkmu.2022.91955
Abstract
Coronavirus disease 2019 (COVID-19) has caused a huge burden across the world. COVID-19 affects not only physical health but also neuropsychiatric health. Reported neuropsychiatric presentations due to COVID-19 include encephalopathy, mood changes, and neuromuscular dysfunction, which may occur during the infection. There have been also reports showing that the COVID-19 could provoke psychosis during the infection. However, there is still no available evidence regarding this event. In this report, three uncommon cases of new-onset psychosis with mild symptoms of COVID-19 admitted to Bali Provincial Mental Hospital in Bangli, Indonesia are described. The patients had presented persecutory delusions and auditory hallucinations. None of the patients had suicidal ideation or behavior. Three of the cases met the criteria for brief psychosis according to Indonesia’s guidelines for mental health disorders and classification. This report showed brief psychosis without suicidal ideation. However, clinicians have to be more alert in treating this condition due to its potential emergency risk shown in previous reports.

Keywords

Keywords: COVID-19
Pandemic
Brief reactive
Psychosis
  1. He F, Deng Y, Li W. Coronavirus disease 2019: What we know? J Med Virol. 2020; 92(7):719-25. doi: 10.1002/jmv.25766.
  2. Olivia S, Gibson J, Nasrudin R. Indonesia in the time of Covid-19. Bulletin of Indonesian Economic Studies. 2020; 56(2):143-74. doi: 10.1080/00074918.2020.1798581.
  3. Byrne A, Barber R, Lim CH. Impact of the COVID-19 pandemic a mental health service perspective. Prog Neurol Psychiatry. 2021; 25(2):27-33. doi: 10.1002/pnp.708.
  4. Pfefferbaum B, North CS. Mental Health and the Covid-19 Pandemic. N Engl J Med. 2020; 383(6):510-12. doi: 10.1056/NEJMp2008017.
  5. Hsu ST, Chou LS, Chou FH, Hsieh KY, Chen CL, Lu WC, et al. Challenge and strategies of infection control in psychiatric hospitals during biological disasters-From SARS to COVID-19 in Taiwan. Asian J Psychiatr. 2020; 54:102270. doi: 10.1016/j.ajp.2020.102270.
  6. Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav 2020; 87:34-39. doi: 10.1016/j.bbi.2020.04.027.
  7. Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. The Lancet Psychiatry. 2021; 8(2):130-40. doi: 10.1016/S2215-0366(20)30462-4. 
  8. Kumar S, Veldhuis A, Malhotra T. Neuropsychiatric and Cognitive Sequelae of COVID-19. Front Psychol. 2021; 12:577529. doi: 10.3389/fpsyg.2021.577529.
  9. Posel D, Oyenubi A, Kollamparambil U. Job loss and mental health during the COVID-19 lockdown: Evidence from South Africa. PLoS ONE. 2021; 16(3): e0249352. doi: 10.1371/journal.pone.0249352.
  10. Pan KY, Kok AAL, Eikelenboom M, Horsfall M, Jorg F, Luteijn RA, et al. The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts. Lancet Psychiatry. 2020; 8(2):121-29. doi: 10.1016/S2215-0366(20)30491-0.
  11. Ferrando SJ, Klepacz L, Lynch S, Tavakkoli M, Dornbush R, Baharani R, et al. COVID-19 Psychosis: A potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response? Psychosomatics. 2020; 61(5):551-55. doi: 10.1016/j.psym.2020.05.012. 
  12. Parra A, Juanes A, Losada CP, Álvarez-Sesmero S, Santana VD, Martí I, et al. Psychotic symptoms in COVID-19 patients: A retrospective descriptive study. Psychiatry Res. 2020; 291:113254. doi: 10.1016/j.psychres.2020.113254.
  13. Severance EG, Dickerson FB, Viscidi RP, Bossis I, Stallings CR, Origoni AE, et al. Coronavirus immunoreactivity in individuals with a recent onset of psychotic symptoms. Schizophr Bull. 2011; 37(1):101-7. doi: 10.1093/schbul/sbp052.
  14. Jasti M, Nalleballe K, Dandu V, Onteddu S. A review of pathophysiology and neuropsychiatric manifestations of COVID-19. J Neurol. 2021; 268(6):2007-12. doi: 10.1007/s00415-020-09950-w.
  15. Hamm BS, Rosenthal LJ. Psychiatric Aspects of Chloroquine and Hydroxychloroquine Treatment in the Wake of Coronavirus Disease-2019: Psychopharmacological Interactions and Neuropsychiatric Sequelae. Psychosomatics. 2020; 61(6):597-606. doi: 10.1016/j.psym.2020.06.022.
  16. Zareifopoulos N, Panayiotakopoulos G. Neuropsychiatric Effects of Antimicrobial Agents. Clin Drug Investig. 2017; 37(5):423-37. doi: 10.1007/s40261-017-0498-z.
  17. Kogan Y, Elias N, Paz A, Odeh M. Acute Delirium Associated With Levofloxacin. J Clin Med Res. 2018; 10(9):725-27. doi: 10.14740/jocmr3538w.
  18. Huh K, Kang M, Shin DH, Hong J, Jung J. Oseltamivir and the Risk of Neuropsychiatric Events: A National, Population-based Study. Clin Infect Dis. 2020; 71(9):409-14. doi: 10.1093/cid/ciaa055.
  19. Mohebbi N, Talebi A, Moghadamnia M, Nazari Taloki Z, Shakiba A. Drug Interactions of Psychiatric and COVID-19 Medications. Basic Clin Neurosci. 2020; 11(2):185-200. doi: 10.32598/bcn.11.covid19.2500.1.
  20. Gillett G, Jordan I. Severe psychiatric disturbance and attempted suicide in a patient with COVID-19 and no psychiatric history. BMJ Case Rep. 2020; 13(10):e239191. doi: 10.1136/bcr-2020-239191.

 

Journal of Kerman University of Medical Sciences
Volume 29, Issue 3
May and June 2022
Pages 296-300

Home

Editorial Board

Guide for Authors

Submit Manuscript

Guide for Reviewers

Contact Us